Middleton & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17M | Sell |
78,048
-1,350
| -2% | -$299K | 1.94% | 12 |
|
|
2025
Q4 | $18.1M | Sell |
79,398
-702
| -0.9% | -$160K | 1.93% | 11 |
|
|
2025
Q3 | $18.5M | Sell |
80,100
-2,804
| -3% | -$571K | 2% | 12 |
|
|
2025
Q2 | $15.4M | Sell |
82,904
-3,666
| -4% | -$681K | 1.73% | 15 |
|
|
2025
Q1 | $18.1M | Sell |
86,570
-157
| -0.2% | -$30.5K | 2.12% | 11 |
|
|
2024
Q4 | $15.4M | Sell |
86,727
-252
| -0.3% | -$46.3K | 1.7% | 16 |
|
|
2024
Q3 | $17.2M | Sell |
86,979
-664
| -0.8% | -$124K | 1.9% | 15 |
|
|
2024
Q2 | $15M | Sell |
87,643
-1,755
| -2% | -$291K | 1.75% | 18 |
|
|
2024
Q1 | $16.3M | Sell |
89,398
-830
| -0.9% | -$143K | 1.88% | 14 |
|
|
2023
Q4 | $14M | Sell |
90,228
-879
| -1% | -$128K | 1.74% | 17 |
|
|
2023
Q3 | $13.6M | Sell |
91,107
-763
| -0.8% | -$112K | 1.88% | 13 |
|
|
2023
Q2 | $12.4M | Sell |
91,870
-8,981
| -9% | -$1.32M | 1.64% | 17 |
|
|
2023
Q1 | $16.1M | Sell |
100,851
-1,359
| -1% | -$208K | 2.31% | 9 |
|
|
2022
Q4 | $16.5M | Buy |
102,210
+54
| +0.1% | +$8.28K | 2.45% | 8 |
|
|
2022
Q3 | $13.7M | Sell |
102,156
-3,461
| -3% | -$497K | 2.09% | 12 |
|
|
2022
Q2 | $16.2M | Sell |
105,617
-11,081
| -9% | -$1.69M | 2.07% | 12 |
|
|
2022
Q1 | $18.9M | Sell |
116,698
-7,476
| -6% | -$1.09M | 2.02% | 11 |
|
|
2021
Q4 | $16.8M | Sell |
124,174
-305
| -0.2% | -$36K | 1.64% | 19 |
|
|
2021
Q3 | $13.4M | Buy |
124,479
+100
| +0.1% | +$11.4K | 1.44% | 26 |
|
|
2021
Q2 | $14M | Sell |
124,379
-10,553
| -8% | -$1.19M | 1.52% | 20 |
|
|
2021
Q1 | $14.6M | Buy |
134,932
+2,597
| +2% | +$278K | 1.65% | 18 |
|
|
2020
Q4 | $14.2M | Buy |
132,335
+175
| +0.1% | +$16.8K | 1.68% | 18 |
|
|
2020
Q3 | $11.6M | Buy |
132,160
+544
| +0.4% | +$51.2K | 1.53% | 22 |
|
|
2020
Q2 | $12.9M | Buy |
131,616
+3,185
| +2% | +$280K | 1.86% | 14 |
|
|
2020
Q1 | $9.79M | Sell |
128,431
-1,827
| -1% | -$156K | 1.71% | 18 |
|
|
2019
Q4 | $11.5M | Sell |
130,258
-4,606
| -3% | -$382K | 1.64% | 22 |
|
|
2019
Q3 | $10.2M | Sell |
134,864
-2,669
| -2% | -$183K | 1.57% | 22 |
|
|
2019
Q2 | $10M | Sell |
137,533
-1,758
| -1% | -$138K | 1.55% | 24 |
|
|
2019
Q1 | $11.2M | Buy |
139,291
+1,821
| +1% | +$149K | 1.8% | 16 |
|
|
2018
Q4 | $12.7M | Sell |
137,470
-5,429
| -4% | -$477K | 2.33% | 9 |
|
|
2018
Q3 | $13.5M | Buy |
142,899
+5,463
| +4% | +$518K | 2.11% | 8 |
|
|
2018
Q2 | $12.7M | Buy |
137,436
+1,265
| +0.9% | +$124K | 2.18% | 9 |
|
|
2018
Q1 | $12.9M | Sell |
136,171
-14,286
| -9% | -$1.57M | 2.31% | 7 |
|
|
2017
Q4 | $14.6M | Buy |
150,457
+10,086
| +7% | +$951K | 2.44% | 6 |
|
|
2017
Q3 | $12.5M | Sell |
140,371
-127
| -0.1% | -$9.67K | 2.25% | 8 |
|
|
2017
Q2 | $10.2M | Buy |
140,498
+2,180
| +2% | +$147K | 2.17% | 10 |
|
|
2017
Q1 | $9.01M | Sell |
138,318
-2,492
| -2% | -$157K | 1.98% | 12 |
|
|
2016
Q4 | $8.82M | Sell |
140,810
-8,259
| -6% | -$504K | 1.99% | 13 |
|
|
2016
Q3 | $9.4M | Sell |
149,069
-5,892
| -4% | -$381K | 2.11% | 11 |
|
|
2016
Q2 | $9.59M | Sell |
154,961
-3,613
| -2% | -$220K | 2.21% | 9 |
|
|
2016
Q1 | $9.06M | Sell |
158,574
-406
| -0.3% | -$22.6K | 2.1% | 14 |
|
|
2015
Q4 | $9.42M | Buy |
158,980
+18,329
| +13% | +$1.06M | 2.1% | 14 |
|
|
2015
Q3 | $7.65M | Buy |
140,651
+22,918
| +19% | +$1.49M | 1.81% | 19 |
|
|
2015
Q2 | $7.91M | Buy |
117,733
+58,693
| +99% | +$3.83M | 1.71% | 18 |
|
|
2015
Q1 | $3.46M | Buy |
59,040
+37,167
| +170% | +$2.25M | 0.76% | 46 |
|
|
2014
Q4 | $1.43M | Buy |
21,873
+2,907
| +15% | +$183K | 0.32% | 74 |
|
|
2014
Q3 | $1.1M | Sell |
18,966
-42
| -0.2% | -$2.33K | 0.26% | 80 |
|
|
2014
Q2 | $1.07M | Sell |
19,008
-650
| -3% | -$34.1K | 0.24% | 85 |
|
|
2014
Q1 | $1.01M | Sell |
19,658
-281
| -1% | -$14.2K | 0.24% | 86 |
|
|
2013
Q4 | $1.05M | Sell |
19,939
-359
| -2% | -$17.6K | 0.28% | 67 |
|
|
2013
Q3 | $908K | Sell |
20,298
-927
| -4% | -$41.1K | 0.24% | 81 |
|
|
2013
Q2 | $877K | Buy |
+21,225
| New | +$928K | 0.26% | 79 |
|
Other funds holding ABBV
VCM
VPM
Middleton & Co's ABBV Position: Q1 2026 in Review
Middleton & Co reduced its AbbVie (ABBV) stake by 1.7% in Q1 2026, selling an estimated $299K and leaving 78,048 shares worth $17M. The position accounts for 1.94% of the portfolio, ranked #12.
Middleton & Co first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.9M in Q1 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Middleton & Co held 78,048 shares of AbbVie worth $17M as of Q1 2026.
- Middleton & Co sold 1,350 AbbVie shares in Q1 2026, an estimated $299K.
- AbbVie made up 1.94% of Middleton & Co's portfolio in Q1 2026, its #12 holding.
- Middleton & Co first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Middleton & Co's AbbVie position peaked at $18.9M in Q1 2022.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Middleton & Co's 13F filing for Q1 2026, filed 8 May 2026.